Radiprodil

2 trials 1 recruiting Orphan designation

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

1 Sponsors

8 Countries

Phase III

Phase I/II

Phase III: 1 Phase I/II: 1

Oversight events:

1 urgent safety measure 1 corrective measure across 1 trial

View oversight register →

Indications tested

Neurodevelopmental disorder 1 Tuberous sclerosis complex 1

Sponsors using this IMP

Grin Therapeutics Inc. 2

All trials

2 total

A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Ope… Recruiting

2023-509672-42-00 Phase III 8 countries Grin Therapeutics Inc.
A Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms of Radi… Ended

2023-506301-20-00 Phase I/II 5 countries Grin Therapeutics Inc.

Showing 1–2 of 2 trials

← All drugs A–Z